EnglishSpanishDrug Class & Related Drugs
Diabetes is a chronic illness that is globally of epidemic proportions. According the most recent statistics 1 in 10 adults worldwide suffer from diabetes, that is, a global average prevalence of approximately 10%, although in some nations, for example, Pacific Islands one third of the population have diabetes.1,2,3 Over 90% of the cases of diabetes worldwide are type 2 diabetes (formerly called non-insulin-dependent or adult-onset diabetes – but now cases are being seen in children) which results from defective insulin production due to insulin resistance, and is characterised by the ineffective use of insulin to control glucose metabolism, and the disease is exacerbated by obesity, diets containing high levels of refined carbohydrate and fats, and lack of physical activity. Type 1 diabetes (previously known as insulin-dependent, juvenile or childhood-onset) comes about because of pancreatic beta cell destruction, and is characterized by deficient insulin production and people with type 1 diabetes have to receive an exogenous source of insulin from
the start.
the start.
La diabetes es una enfermedad de distribución universal. El término diabetes, considerado en forma aislada, significa “pasar a través”. Hace muchos siglos este concepto fue atribuido a una supuesta alteración renal responsable de la producción de poliuria, uno de los signos característicos de la enfermedad. Desde el punto de vista clínico, la diabetes mellitus suele presentarse en dos momentos de la vida, denominándose diabetes juvenil a aquella observada preferentemente en la adolescencia o juventud temprana y diabetes del adulto, a aquella que afecta al individuo maduro.
Actos pioglitazone class: thiazolidinediones
Amaryl glimepiride class: sulfonylureas
Bydureon exenatide class: incretin mimetics
Byetta exenatide class: incretin mimetics
Farxiga dapagliflozin class: SGLT-2 inhibitors
Glucophage metformin class: non-sulfonylureas
Glucotrol glipizide class: sulfonylureas
Humalog insulin lispro class: insulin
Invokana canagliflozin class: SGLT-2 inhibitors
Janumet metformin/sitagliptin class: antidiabetic combinations
Januvia sitagliptin class: dipeptidyl peptidase 4 inhibitors
Kombiglyze XR metformin/saxagliptin class: antidiabetic combinations
Lantus insulin glargine class: insulin
Lantus Solostar insulin glargine class: insulin
Levemir insulin detemir class: insulin
Novolog insulin aspart class: insulin
Onglyza saxagliptin class: dipeptidyl peptidase 4 inhibitors
Tradjenta linagliptin class: dipeptidyl peptidase 4 inhibitors
Victoza liraglutide class: incretin mimetics
Welchol colesevelam class: bile acid sequestrants
Amaryl glimepiride class: sulfonylureas
Bydureon exenatide class: incretin mimetics
Byetta exenatide class: incretin mimetics
Farxiga dapagliflozin class: SGLT-2 inhibitors
Glucophage metformin class: non-sulfonylureas
Glucotrol glipizide class: sulfonylureas
Humalog insulin lispro class: insulin
Invokana canagliflozin class: SGLT-2 inhibitors
Janumet metformin/sitagliptin class: antidiabetic combinations
Januvia sitagliptin class: dipeptidyl peptidase 4 inhibitors
Kombiglyze XR metformin/saxagliptin class: antidiabetic combinations
Lantus insulin glargine class: insulin
Lantus Solostar insulin glargine class: insulin
Levemir insulin detemir class: insulin
Novolog insulin aspart class: insulin
Onglyza saxagliptin class: dipeptidyl peptidase 4 inhibitors
Tradjenta linagliptin class: dipeptidyl peptidase 4 inhibitors
Victoza liraglutide class: incretin mimetics
Welchol colesevelam class: bile acid sequestrants
